These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2554046

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK, Kanes W, Davidson PT, Moulding TS.
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [Abstract] [Full Text] [Related]

  • 23. [A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. A fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria].
    Takenaka T, Tsukamura M.
    Kekkaku; 1970 Mar; 45(3):93-6. PubMed ID: 4987506
    [No Abstract] [Full Text] [Related]

  • 24. [Antibacterial activity of enviomycin for atypical mycobacteria. 1. Antibacterial activity in vitro (author's transl)].
    Toyohara M.
    Kekkaku; 1978 Apr; 53(4):255-60. PubMed ID: 661057
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
    Yamazaki T, Sato N, Yamashita K, Okazawa Y, Miyao H, Tanno K.
    Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
    [Abstract] [Full Text] [Related]

  • 28. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
    Toyohara M.
    Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
    Yamane N, Onaga S, Saitoh H, Toyoshima S, Shimojima M, Kawahara S, Takashima T, Yamashita T.
    Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J, Bönicke R.
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract] [Full Text] [Related]

  • 34. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
    Tsukamura M, Ichiyama S.
    Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933
    [No Abstract] [Full Text] [Related]

  • 35. [Resistance behavior of atypical mycobacteria to antibiotics and sulfonamides].
    Neubert R.
    Z Erkr Atmungsorgane; 1986 Feb; 167(1-2):47-51. PubMed ID: 3765715
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
    Fukuhara Y.
    Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
    [No Abstract] [Full Text] [Related]

  • 38. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
    Cavicchioli M, Leite CQ, Sato DN, Massabni AC.
    Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
    [Abstract] [Full Text] [Related]

  • 39. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.
    Juréen P, Angeby K, Sturegård E, Chryssanthou E, Giske CG, Werngren J, Nordvall M, Johansson A, Kahlmeter G, Hoffner S, Schön T.
    J Clin Microbiol; 2010 May; 48(5):1853-8. PubMed ID: 20237102
    [Abstract] [Full Text] [Related]

  • 40. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
    Mineshita M, Miyazawa T, Doi M, Suei S, Matsuura M, Senoo T, Yamakido M.
    Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.